Skip to content

Transcutaneous Electrical Nerve Stimulation During Exercise in Patients With COPD

Effects of Transcutaneous Electrical Nerve Stimulation During Acute Aerobic Exercise in Patients With Chronic Obstructive Pulmonary Disease After Exacerbation

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03548870
Acronym
proTENS
Enrollment
2
Registered
2018-06-07
Start date
2021-10-23
Completion date
2024-10-08
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Physical Activity, Rehabilitation, TEN

Brief summary

Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training. Several studies showed that transcutaneous electrical nerve stimulation (TENS) could improve dyspnea and pulmonary function. The aim of this study is to assess the acute effect of TENS on exercise tolerance in post-exacerbation COPD patients

Interventions

OTHERCWRT with low frequency transcutaneous electrical nerve stimulation

4 self adhesive surface electrodes will be positioned by pair on quadriceps. Patients will have a low frequency TENS for 20 min at rest. During this period, intensity will be increased every 5 minutes to the maximum tolerated by the patient (below pain threshold, sensation strong but comfortable). Thereafter, intensity is not increased anymore during the test. Current characteristics : Rehab 400, CefarCompex 5Hz 200 µs frequency bidirectional

OTHERCWRT with sham-low frequency transcutaneous electrical nerve stimulation

4 self adhesive surface electrodes are positioned by pair on quadriceps. Patients will have a sham-low frequency TENS for 20 min at rest. During this period, intensity will be increased for 1 minute to the maximum tolerated by the patient. After this procedure, intensity will be progressively setted back to 1mA. Current characteristics : Rehab 400, CefarCompex 5Hz 200 µs frequency bidirectional

Sponsors

Groupe Hospitalier du Havre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

sham transcutaneous electrical nerve stimulation

Eligibility

Sex/Gender
ALL
Age
35 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* a diagnosis of COPD

Exclusion criteria

* exercise contraindication Any musculoskeletal problems, cardiovascular or * neurological comorbidities that limits exercise. * pH \< 7,35 * Body temperature \> 38°C * cardiac frequency \> 100 bpm at rest * systolic blood pressure \< 100 mmHg * exacerbation during the study * heart pace-maker or defibrillator * Opiate treatment during the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
comparison of exercise tolerancetwo CWRET will be carried out in different days, separate from 24 hours minimum for a total time frame of 5 days maximumComparison of endurance time (Tlim, in second) during constant workload testing (CWRET) under 2 conditions

Secondary

MeasureTime frameDescription
Difference in peripheral muscle oxygenationThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseMuscle oxygenation (arbitrary unit) will be evaluated using Near-infrared spectroscopy technology.
Difference in DyspneaThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in dyspnea using Modified Borg Scale (0 - 10 points) 0=no dyspnea ; 10 = maximal effort
Difference in Oxygen SaturationThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in Oxygen Saturation (%) using a pulse oximetry (SpO2)
Difference in Cardiac FrequencyThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in Cardiac Frequence (bpm) using a pulse oximetry
Difference in muscular fatigueThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in muscular fatigue using Modified Borg Scale (0 - 10 points) 0=no muscular fatigue ; 10 = maximal effort
Difference in oxygen consumptionThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in oxygen consumption (milliliters per minute) will be measured breath-by-breath using a computer-based exercise system
Difference in carbon dioxide productionThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in carbon dioxide production (milliliters per minute) will be measured breath-by-breath using a computer-based exercise system
Difference in minute ventilationThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in minute ventilation (liters per minute) will be measured breath-by-breath using a computer-based exercise system
Difference in tidal volumeThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in tidal volume (Liters) will be measured breath-by-breath using a computer-based exercise system
Difference in respiratory rateThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in respiratory rate (cycles per minute) will be measured breath-by-breath using a computer-based exercise system
Difference in inspiratory capacityThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in inspiratory capacity (Liters) will be measured breath-by-breath using a computer-based exercise system
Difference in respiratory quotientThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exerciseDifference in respiratory quotient (ratio) will be measured breath-by-breath using a computer-based exercise system

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026